Antitumor effect of a combination of lysine, proline, arginine, ascorbic acid, and green tea extract on pancreatic cancer cell line MIA PaCa-2

  • M. Waheed Roomi
  • Vadim Ivanov
  • Tatiana KalinovskyEmail author
  • Aleksandra Niedzwiecki
  • Matthias Rath
Research Article


Background: Current treatment of pancreatic cancer is generally associated with poor prognosis, even if diagnosed early, owing to its aggressive rate of metastasis and non-responsiveness to chemotherapy and radiotherapy. Matrix metalloproteinases (MMPs) have received much attention in recent years for their role in various malignancies, and have been implicated in tumor invasion, metastasis, and angiogenesis.

Aim of Study: Reported antitum or properties of ascorbic acid, lysine, proline, and green tea extract prompted us to investigate the effect of a combination of lysine, proline, arginine, ascorbic acid, and green tea extract on pancreatic cancer cell line MIA PaCa-2 for viability, MMP expression, invasion, and morphology.

Methods: Viability was evaluated based on cell proliferation by MTT assay and MMP expression in condition media by gelatinase zymography. Invasion through Matrigel™ was assayed and morphology was observed by hematoxylin and eosin (H+E)staining. Data was analyzed by independent sample “t” test.

Results: The nutrient mixture (NM) did not inhibit cell proliferation at 10 µg/mL and exhibited a dosedependent antiproliferative effect with maximum inhibition of 38% over the control at demonstrated production of only MMP-9, which showed a dose-dependent decreased expression that was abolished at 100 µg/mL of NM. Invasion through Matrigel was inhibited at 10, 50, 100, and 500 µg/mL by 66%, 66%, 87% and 100%, respectively. H&E staining did not indicate changes even at the highest concentration of NM.

Conclusion: Our results suggest that the formulation of green tea extract, lysine, proline, and ascorbic acid, tested as a promising adjunct to standard treatment of pancreatic cancer, by inhibiting MMP expression and invasion without toxic effects—important parameters in cancer metastasis.

Key Words

Pancreatic cancer MMPs lysine proline ascorbic acid green tea extract antitumor MIA PaCa-2 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Silverman DT, Schiffman M, Everhart J, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 1999;80:1830–1837.PubMedCrossRefGoogle Scholar
  2. 2.
    Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin 2000;50:7–33.PubMedCrossRefGoogle Scholar
  3. 3.
    Rath M and Pauling L. Plasmin-induced proteolysis and the role of apoprotein(a), lysine and synthetic analogs. Orthomolecular Medicine 1992;7:17.Google Scholar
  4. 4.
    Netke SP, Roomi MW, Ivanov V, Niedzwiecki A, Rath, M. A specific combination of ascorbic acid, lysine, proline and epigallocatechin gallate inhibits proliferation and extracellular matrix invasion of various human cancer cell lines. Research Communications in Pharmacology and Toxicology: Emerging Drugs 2003;2: 37.Google Scholar
  5. 5.
    Albini A, Iwamoto Y, Kleinman HK, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987;47:3239–3245.PubMedGoogle Scholar
  6. 6.
    Koh WS, Lee SJ, Lee H, et al. Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines. Anticancer Res 1998;18:2487–2493.PubMedGoogle Scholar
  7. 7.
    Roomi MW, House D, Eckert-Maksic M, Maksic ZB, Tsao CS. Growth suppression of malignant leukemia cell line in vitro by ascorbic acid (vitamin C) and its derivatives. Cancer Lett 1998;122:93–99.PubMedCrossRefGoogle Scholar
  8. 8.
    Naidu KA, Karl RC, Naidu KA, Coppola D. Antiproliferative and proapoptotic effect of ascorbyl stearate in human pancreatic cancer cells: association with decreased expression of insulin-like growth factor 1 receptor. Dig Dis Sci 2003;48:230–237.PubMedCrossRefGoogle Scholar
  9. 9.
    Anthony HM, Schorah CJ. Severe hypovitaminosis C in lung-cancer patients: the utilization of vitamin C in surgical repair and lymphocyte-related host resistance. Br J Cancer 1982;46:354–367.PubMedGoogle Scholar
  10. 10.
    Nunez C, Ortiz de Apodaca Y, Ruiz A. Ascorbic acid in the plasma and blood cells of women with breast cancer: the effect of consumption of food with an elevated content of this vitamin. Nutr Hosp 1995;10:68.Google Scholar
  11. 11.
    Kurbacher CM, Wagner U, Kolster B, Andreotti PE, Krebs D, Bruckner HW. Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro. Cancer Lett 1996;103:183–189.PubMedCrossRefGoogle Scholar
  12. 12.
    Valcic S, Timmermann BN, Alberts DS, Wachter GA, Krutzsch M, Wymer J, Guillen JM. Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anticancer Drugs 1996;7:461–468.PubMedCrossRefGoogle Scholar
  13. 13.
    Mukhtar H and Ahmed N. Tea polypheonols: prevention of cancer and optimizing health. Am J Clin Nutr 2000;71:1698S.Google Scholar
  14. 14.
    Yang GY, Liao J, Kim K, Yurkow EJ, Yang CS. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 1998;19:611–616.PubMedCrossRefGoogle Scholar
  15. 15.
    National Institutes of Health. Website: ( Scholar
  16. 16.
    Meredith CN, Wen ZM, Bier DM, Matthews DE, Young VR. Lysine kinetics at graded lysine intakes in young men. Am J Clin Nutr 1986;43:787–794.PubMedGoogle Scholar
  17. 17.
    Ullmann U, Haller J, Decourt JP, Girault N, Girault J, Richard-Caudron AS, Pineau B, Weber P. A single ascending dose study of epigallocatechin gallate in healthy volunteers. J Int Med Res 2003;31:88–101.PubMedGoogle Scholar

Copyright information

© Humana Press Inc 2005

Authors and Affiliations

  • M. Waheed Roomi
    • 1
  • Vadim Ivanov
    • 1
  • Tatiana Kalinovsky
    • 1
    Email author
  • Aleksandra Niedzwiecki
    • 1
  • Matthias Rath
    • 1
  1. 1.MRI, Cancer Research DivisionSanta Clara

Personalised recommendations